1.Acute amiodarone syndrome after a single intravenous amiodarone bolus.
Xin Rong NG ; Liang Yi WEE ; Veerendra CHADACHAN
Singapore medical journal 2012;53(11):e225-7
Acute amiodarone toxicity after a single dose of intravenous amiodarone is very rarely seen. We report the case of a 64-year-old Chinese man who presented with atrial fibrillation and fluid overload due to congestive cardiac failure. He was treated with a single bolus dose of intravenous amiodarone, after which he developed elevated serum transaminases, coagulopathy, thrombocytopenia and acute renal failure. His parameters returned to normal after 25 days and his recovery was uneventful.
Acute Kidney Injury
;
chemically induced
;
Amiodarone
;
adverse effects
;
Anti-Arrhythmia Agents
;
adverse effects
;
Atrial Fibrillation
;
drug therapy
;
Blood Coagulation Disorders
;
chemically induced
;
Heart Failure
;
complications
;
drug therapy
;
Humans
;
Male
;
Middle Aged
;
Thrombocytopenia
;
chemically induced
;
Transaminases
;
blood
;
Treatment Outcome
2.Acute renal failure following the use of rosiglitazone in a chronic kidney disease patient.
R Abdul GHANI ; S ZAINUDIN ; N A KAMARUDDIN ; N C T KONG
Singapore medical journal 2009;50(1):e32-4
Drug-induced acute interstitial nephritis is a well-recognised and important reversible cause of acute renal failure. Peroxisome-proliferator activated receptor-gamma agonists, such as rosiglitazone, have been proven to be safe in chronic kidney disease patients. We describe a 65-year-old man with long-standing diabetes mellitus and hypertension, presenting with a five-day history of fluid overload and uraemic symptoms. There was no ingestion of analgesics, alternative medicine and other nephrotoxic drugs, the only new prescription being rosiglitazone, which was commenced during his last clinic follow-up two weeks prior to presentation. He required haemodialysis with minimal improvement in renal profile, despite cessation of the offending drug. Renal biopsy revealed findings consistent with acute interstitial nephritis. An episode of upper gastrointestinal bleeding with bleeding duodenal ulcer limited the use of steroids. He was treated with a course of mycophenolate mofetil which showed good gradual response and he remained stable with residual renal impairment.
Acute Kidney Injury
;
chemically induced
;
drug therapy
;
Aged
;
Humans
;
Hypoglycemic Agents
;
adverse effects
;
Immunosuppressive Agents
;
therapeutic use
;
Kidney Failure, Chronic
;
complications
;
Male
;
Mycophenolic Acid
;
analogs & derivatives
;
therapeutic use
;
Renal Dialysis
;
Thiazolidinediones
;
adverse effects
3.Post-treatment Effects of Erythropoietin and Nordihydroguaiaretic Acid on Recovery from Cisplatin-induced Acute Renal Failure in the Rat.
Dong Won LEE ; Ihm Soo KWAK ; Soo Bong LEE ; Sang Heon SONG ; Eun Young SEONG ; Byeong Yun YANG ; Min Young LEE ; Mee Young SOL
Journal of Korean Medical Science 2009;24(Suppl 1):S170-S175
5-Lipoxygenase inhibitor and human recombinant erythropoietin might accelerate renal recovery in cisplatin-induced acute renal failure rats. Male Sprague-Dawley rats were randomized into four groups: 1) normal controls; 2) Cisplatin group-cisplatin induced acute renal failure (ARF) plus vehicle treatment; 3) Cisplatin+nordihydroguaiaretic acid (NDGA) group-cisplatin induced ARF plus 5-lipoxygenase inhibitor treatment; 4) Cisplatin+erythropoietin (EPO) group-cisplatin induced ARF plus erythropoietin treatment. On day 10 (after 7 daily injections of NDGA or EPO), urea nitrogen and serum Cr concentrations were significantly lower in the Cisplatin+NDGA and Cisplatin+EPO groups than in the Cisplatin group, and 24 hr urine Cr clearances were significantly higher in the Cisplatin+EPO group than in the Cisplatin group. Semiquantitative assessments of histological lesions did not produce any significant differences between the three treatment groups. Numbers of PCNA(+) cells were significantly higher in Cisplatin, Cisplatin+NDGA, and Cisplatin+EPO groups than in normal controls. Those PCNA(+) cells were significantly increased in Cisplatin+NDGA group. These results suggest that EPO and also NDGA accelerate renal function recovery by stimulating tubular epithelial cell regeneration.
Animals
;
Arachidonate 5-Lipoxygenase/administration & dosage
;
Blood Urea Nitrogen
;
Cisplatin/*toxicity
;
Creatinine/urine
;
Epithelial Cells/drug effects
;
Erythropoietin/administration & dosage/*therapeutic use
;
Kidney/metabolism
;
Kidney Failure, Acute/*chemically induced/*drug therapy
;
Kidney Tubules/drug effects
;
Male
;
Nordihydroguaiaretic Acid/*therapeutic use
;
Rats
;
Rats, Sprague-Dawley
;
Regeneration